Keyvisual: View into a green forest

Our Portfolio

We take an active role in our portfolio companies, contributing expertise in drug discovery, development and operations.

Direct Investments

Logo: StrideBio, Inc.

StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.

We aim to work with our portfolio companies to help them deliver maximum patient value by contributing both capital and expertise.
  • 28 March 2019. StrideBio and Takeda Sign Collaboration and License Agreement to Advance Novel Gene Therapies for Neurological Diseases

    read more
  • 19 February 2019. CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

    read more
  • 03 January 2019. StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Officer

    read more

Selected Invested Funds

Logo: Arix Bioscience plc

Arix Bioscience supports medical innovation at all stages of development and has access to breakthrough academic science.

Logo: Pappas Capital

Pappas is dedicated to furthering life science discoveries and delivering groundbreaking solutions to market.

Logo: Quiming Venture Partners

Qiming drives innovation and growth of business enterprises and promotes overall industry advancement and social development.